Related StoriesStudy explores diabetes screening for individuals with severe mental illnessSleep loss reduces insulin sensitivity, raises diabetes riskBetalin launches brand-new EMP technology that could transform diabetes treatment The initiation of this Phase II trial for CCX140 can be an important step of progress in identifying a novel treatment for diabetes, a disease that an unmet medical need for safe and convenient therapies persists, stated Thomas J. Schall, Ph.D., Chief and President Executive Officer of ChemoCentryx. This milestone represents another advance inside our mission to deliver best-in-class chemokine-centered therapies for inflammatory diseases.‘Mentor-intern romantic relationships play a pivotal function in developing and traveling a student’s profession choice,’ stated Catherine Ivy, President of The Ben & Catherine Ivy Foundation. ‘It really is my wish that the Ivy Neurological Sciences Internship Plan will inspire additional analysis in to the neurosciences and these learners will become another era of leaders in the field.’ Related StoriesDiscovery can lead to fresh anti-metastasis therapies for advanced-stage brain cancers patientsPatrolling monocytes may play anti-cancer part in the lungSRS microscope technology provides surgeons real-time microscopic eyesight of mind tumorsTGen will go for five college students for the pilot plan, in June which starts.